These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Production of monoclonal antibody against human prostatic adenocarcinoma and its immunohistochemical properties. Matsuki H, Ozono S, Yoshie T, Kubota K, Hirao Y, Konishi N, Hashimoto H, Ohshima M, Hiasa Y, Okajima E. Jpn J Exp Med; 1990 Oct; 60(5):263-72. PubMed ID: 1706786 [Abstract] [Full Text] [Related]
29. Isozymes of acid phosphatase in normal and cancerous human prostatic tissue. Foti AG, Herschman H, Cooper JF. Cancer Res; 1977 Nov; 37(11):4120-4. PubMed ID: 908045 [Abstract] [Full Text] [Related]
30. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Partin AW, Getzenberg RH, CarMichael MJ, Vindivich D, Yoo J, Epstein JI, Coffey DS. Cancer Res; 1993 Feb 15; 53(4):744-6. PubMed ID: 7679049 [Abstract] [Full Text] [Related]
32. [Tumor markers of prostate cancer--evaluation of serum PAP and PA]. Miki M. Gan No Rinsho; 1985 May 15; 31(6 Suppl):664-9. PubMed ID: 2411965 [Abstract] [Full Text] [Related]
36. Prostate antigen: a new potential marker for prostatic cancer. Wang MC, Papsidero LD, Kuriyama M, Valenzuela LA, Murphy GP, Chu TM. Prostate; 1981 May 15; 2(1):89-96. PubMed ID: 6169079 [Abstract] [Full Text] [Related]
37. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. Carter HB, Morrell CH, Pearson JD, Brant LJ, Plato CC, Metter EJ, Chan DW, Fozard JL, Walsh PC. Cancer Res; 1992 Jun 15; 52(12):3323-8. PubMed ID: 1375867 [Abstract] [Full Text] [Related]